Treatment with mycophenolate mofetil followed by recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes resistant to erythropoietin treatment

MeSH terms

• Drug Resistance
• Erythropoietin / pharmacology
• Erythropoietin / therapeutic use*
• Humans
• Immunosuppressive Agents / therapeutic use*
• Mycophenolic Acid / analogs & derivatives*
• Mycophenolic Acid / therapeutic use
• Myelodysplastic Syndromes / drug therapy*
• Recombinant Proteins